The global elbow replacement market size was estimated to be USD 139.5 million in 2023 and is expected to reach at USD 350.9 million by 2034 with a CAGR of 8.75% during the forecast period 2024-2034. Rising prevalence of orthopedic disorders such as osteoporosis & osteoarthritis, increased engagement in sports & physical activities leading to trauma & fractures, a growing demand for minimally invasive procedures, surge in adoption of advanced technologies by surgeons, continuous enhancements in minimally invasive techniques, rising technological innovations, ongoing research & development efforts, heightened government funding in the orthopedic field, and increasing introduction of advanced elbow replacement products are some of the key factors boosting the market growth.
Elbow replacement is a surgical procedure involving the surgical replacement of the damaged surfaces of the humerus and ulna at the elbow joint with artificial implants. Hence, increasing introduction of advanced elbow replacement products is predicted to boost the market growth during the forecast period. For instance, in August 2022, OSSIO, Inc., a company specializing in orthopedic fixation technology, introduced OSSIOfiber Suture Anchors, thereby increasing the availability of the company's expanding range of bio-integrative implants. These implants are utilized in surgeries involving the foot/ankle, shoulder, knee, hand/wrist, and elbow, broadening patient access to advanced orthopedic solutions.
By procedure type, total elbow replacement was the highest revenue-grossing segment in the global Elbow Replacement Market in 2023 owing to the surge in number of patient, advancements in technologies, an increasing occurrence of arthritis, ongoing research initiatives, and rising government funding in the field. Additionally, partial elbow replacement is predicted to grow at the fastest CAGR during the forecast period. This procedure entails the replacement of solely the impaired segment of the joint with an artificial implant, aiming to preserve the unaffected portions, and it involves intensified research and development efforts. For instance, in November 2023, A clinical trial titled "Effects of Dual Task on Physical Function in Patients With Elbow Joint Fracture (DTelbow)," sponsored by the University of Valencia, aims to assess neuromuscular responses, pain intensity, and Rating of Perceived Exertion (RPE) in individuals with elbow joint fractures. The study encompasses patients with or without a surgical approach and employs varied strategies to enhance upper limb strength.
By end-user, hospitals was the highest revenue-grossing segment in the global Elbow Replacement Market in 2023 owing to the accessibility & provision of state-of-the-art treatment choices in medical facilities, an increasing incidence of sports-related injuries, the presence of appealing reimbursement policies facilitated by Medicare & Medicaid, and a rise in the volume of surgeries conducted. For instance, in June 2022, Tata Steel Medica Hospital, situated in Duburi, Jajpur district of Odisha, achieved another significant milestone by successfully performing a total elbow replacement surgery on a 70-year-old patient named Mr. Chandra Mohan Tiu. Additionally, orthopedic clinics is predicted to grow at the fastest CAGR during the forecast period owing to the rising incidence of orthopedic disorders and increased investments for the incorporation of advanced devices.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of rheumatoid arthritis and elbow injuries, a surge in advanced technology, a heightened awareness among individuals regarding extremities implants, a rise in product launches, and an augmented awareness regarding bone health. For instance, in May 2022, The Canadian Orthopaedic Association launched 'Canadian Orthopaedic Care Day' nationwide. An innovative effort led by AdvoOrtho, in collaboration with the Canadian Orthopaedic Association, the day is dedicated to promoting awareness and commemorating Orthopaedic care in Canada. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the existence of well-established healthcare infrastructure, a growing demand for advanced healthcare services, an increase in orthopedic procedures, and a surge in the introduction of new products. For instance, in October 2023, Smith+Nephew, the global medical technology company, is excited to introduce its REGENETEN Bioinductive Implant, providing access to numerous patients in Japan.
Elbow replacement is a surgical procedure involving the surgical replacement of the damaged surfaces of the humerus and ulna at the elbow joint with artificial implants. Hence, increasing introduction of advanced elbow replacement products is predicted to boost the market growth during the forecast period. For instance, in August 2022, OSSIO, Inc., a company specializing in orthopedic fixation technology, introduced OSSIOfiber Suture Anchors, thereby increasing the availability of the company's expanding range of bio-integrative implants. These implants are utilized in surgeries involving the foot/ankle, shoulder, knee, hand/wrist, and elbow, broadening patient access to advanced orthopedic solutions.
By procedure type, total elbow replacement was the highest revenue-grossing segment in the global Elbow Replacement Market in 2023 owing to the surge in number of patient, advancements in technologies, an increasing occurrence of arthritis, ongoing research initiatives, and rising government funding in the field. Additionally, partial elbow replacement is predicted to grow at the fastest CAGR during the forecast period. This procedure entails the replacement of solely the impaired segment of the joint with an artificial implant, aiming to preserve the unaffected portions, and it involves intensified research and development efforts. For instance, in November 2023, A clinical trial titled "Effects of Dual Task on Physical Function in Patients With Elbow Joint Fracture (DTelbow)," sponsored by the University of Valencia, aims to assess neuromuscular responses, pain intensity, and Rating of Perceived Exertion (RPE) in individuals with elbow joint fractures. The study encompasses patients with or without a surgical approach and employs varied strategies to enhance upper limb strength.
By end-user, hospitals was the highest revenue-grossing segment in the global Elbow Replacement Market in 2023 owing to the accessibility & provision of state-of-the-art treatment choices in medical facilities, an increasing incidence of sports-related injuries, the presence of appealing reimbursement policies facilitated by Medicare & Medicaid, and a rise in the volume of surgeries conducted. For instance, in June 2022, Tata Steel Medica Hospital, situated in Duburi, Jajpur district of Odisha, achieved another significant milestone by successfully performing a total elbow replacement surgery on a 70-year-old patient named Mr. Chandra Mohan Tiu. Additionally, orthopedic clinics is predicted to grow at the fastest CAGR during the forecast period owing to the rising incidence of orthopedic disorders and increased investments for the incorporation of advanced devices.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing prevalence of rheumatoid arthritis and elbow injuries, a surge in advanced technology, a heightened awareness among individuals regarding extremities implants, a rise in product launches, and an augmented awareness regarding bone health. For instance, in May 2022, The Canadian Orthopaedic Association launched 'Canadian Orthopaedic Care Day' nationwide. An innovative effort led by AdvoOrtho, in collaboration with the Canadian Orthopaedic Association, the day is dedicated to promoting awareness and commemorating Orthopaedic care in Canada. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the existence of well-established healthcare infrastructure, a growing demand for advanced healthcare services, an increase in orthopedic procedures, and a surge in the introduction of new products. For instance, in October 2023, Smith+Nephew, the global medical technology company, is excited to introduce its REGENETEN Bioinductive Implant, providing access to numerous patients in Japan.
Segmentation: Elbow Replacement Market Report 2023 - 2034
Elbow Replacement Market Analysis & Forecast by Procedure Type 2023 - 2034 (Revenue USD Mn)
- Partial Elbow Replacement
- Total Elbow Replacement
Elbow Replacement Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Hospitals
- Orthopedic Clinics
- Others
Elbow Replacement Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Elbow Replacement Market: Procedure Type Estimates & Trend Analysis
8. Elbow Replacement Market: End-user Estimates & Trend Analysis
9. Regional Market Analysis
10. North America Elbow Replacement Market
11. Europe Global Elbow Replacement Market
12. Asia Pacific Global Elbow Replacement Market
13. Latin America Global Elbow Replacement Market
14. MEA Global Elbow Replacement Market
15. Competitor Analysis
16. Company Profiles
Companies Mentioned
- Johnson & Johnson
- DePuy Synthes
- Zimmer Biomet
- Lima Corporate
- Smith+Nephew
- Wright Medical Group N.V.
- Ottobock SE & Co. KGaA
- Arthrex Inc.
- Stryker Corporation
- Corin Group
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 139.5 Million |
| Forecasted Market Value ( USD | $ 350.9 Million |
| Compound Annual Growth Rate | 8.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
